Hungary approves China’s Sinopharm Covid-19 vaccine
Budapest: Hungary authorized the use of China’s Sinopharm Covid-19 vaccine, Hungarian Chief Medical Officer Cecilia Muller said.
“Today the National Institute of Pharmacy and Nutrition gave its approval for the Sinopharm vaccine,” Muller told a briefing, Xinhua news agency reported on Saturday.
Besides the Pfizer-BioNTech and Moderna vaccines acquired through the European Union, Hungary has also approved Russia’s Sputnik V and the British AstraZeneca Covid-19 vaccines.
As the world is struggling to contain the pandemic, vaccination is underway in some countries with the already-authorized coronavirus vaccines.
Meanwhile, 236 candidate vaccines are still being developed worldwide — 63 of them in clinical trials — in countries including Germany, China, Russia, Britain and the United States, according to information released by the World Health Organization on Tuesday.